PHRI research has led to more than 3,000 published papers in renowned medical journals. Several of these papers are “citation classics,” with more than 1,000 citations, with the HOPE main paper reaching 5,000 citations in 2014.
|OASIS-4||Clopidogrel||Unstable Angina/Non-ST Elevation MI|
|OASIS-5||Fondaparinux||Unstable Angina/Non-ST Elevation MI|
|OASIS-6||Fondaparinux||ST Elevation MI|
|ONTARGET/TRANSCEND||Telmisartan||Prevention of Cardiovascular Disease|
|RE-LY||Dabigatran||Prevention of Stroke in Atrial Fibrilation|
|AVERROES||Apixaban||Prevention of Stroke in Atrial Fibrilation|
Benin Republic, Botswana, Cameroon, Ghana, Kenya, Mozambique, Nigeria, Seychelles, Sierra Leone, South Africa, Sudan, Tanzania, Uganda, Zimbabwe.
Bahrain, Bangladesh, China, Hong Kong, India, Indonesia, Iran, Israel, Japan, Kuwait, Malaysia, Nepal, Oman, Pakistan, Philippines, Qatar, Russia, Saudi Arabia, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Turkey, United Arab Emirates.
Austria, Belarus, Bulgaria, Belgium, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom.
Australia, New Zealand
Bermuda, Canada, Cuba, El Salvador, Guatemala, Mexico, United States.
Argentina, Brazil, Chile, Colombia, Ecuador, Peru, Uruguay, Venezuela.